UK markets close in 5 hours 9 minutes

Daiichi Sankyo Company, Limited (DSKYF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
26.75-0.24 (-0.89%)
At close: 02:30PM EST
Full screen
Trade prices are not sourced from all markets
Previous close26.99
Open26.72
Bid0.00 x 0
Ask0.00 x 0
Day's range26.56 - 26.86
52-week range23.45 - 37.91
Volume3,327
Avg. volume11,227
Market cap51.289B
Beta (5Y monthly)0.40
PE ratio (TTM)51.44
EPS (TTM)0.52
Earnings dateN/A
Forward dividend & yield0.30 (1.12%)
Ex-dividend date28 Mar 2024
1y target est35.99
  • Reuters

    Japan panel recommends approval of updated Daiichi Sankyo COVID shot- Kyodo

    A Japanese health ministry panel on Monday recommended approval for an updated version of Daiichi Sankyo's COVID-19 vaccine, the Kyodo news agency said. The mRNA-based shot was initially approved as a booster in August, becoming Japan's first home-grown shot for the coronavirus. The vaccine was updated to provide protection against the XBB.1.5 Omicron subvariant, a contingent for the health ministry to buy 1.4 million doses.

  • Reuters

    IHH Healthcare unit sues Japan's Daiichi Sankyo over Fortis deal

    On Oct, 16, Northern TK Venture filed a claim against the Japanese pharmaceuticals manufacturer stating it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018. IHH Healthcare in December 2018 halted its open offer to buy an additional 26% stake in Fortis after a court ruling ordered status quo to be maintained after Daiichi filed a contempt plea against Fortis founders, according to media reports. "The claims filed by NTK against Daiichi Sankyo are tort claims premised on the latter's unlawful interference with NTK’s trade or business, conspiracy of Daiichi Sankyo and other persons, malicious falsehood and defamation under the applicable substantive laws," IHH Healthcare said on Tuesday.

  • Reuters

    UPDATE 1-IHH Healthcare unit sues Japan's Daiichi Sankyo over Fortis deal

    Malaysia's IHH Healthcare on Tuesday said its unit filed a claim against Japan's Daiichi Sankyo in mid-October seeking damages in excess of 20 billion yen ($131.86 million) in relation to its stake buy in India's Fortis Healthcare. On Oct, 16, Northern TK Venture filed a claim against the Japanese pharmaceuticals manufacturer stating it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018. IHH Healthcare in December 2018 halted its open offer to buy an additional 26% stake in Fortis after a court ruling ordered status quo to be maintained after Daiichi filed a contempt plea against Fortis founders, according to media reports.